Correction to: Dinutuximab beta in high-risk neuroblastoma: a profile of its use
Crossref DOI link: https://doi.org/10.1007/s40267-018-0526-y
Published Online: 2018-06-06
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McKeage, Kate
Lyseng-Williamson, Katherine A.
Text and Data Mining valid from 2018-06-06
Article History
First Online: 6 June 2018